ATLASATLAS fair value
₩6,272
Below fair value · 19% discount
Range: ₩5,645–₩6,899Fair valuePrice
Prestige BioPharma (950210.KO)
Prestige BioPharma stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · Korea Exchange (KOSPI) · South Korea
₩5,050▼ -0.20%
Prices as of Oct 27, 2026 · KRW
Chance of rising in 1 month
48%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Prestige BioPharma in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Prestige BioPharma
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Prestige BioPharma's fair value at about ₩6,272 per share (reasonable range: ₩5,645 to ₩6,899). At ₩5,050, the stock trades 19% below it.
It is calculated with valuation multiples of comparable companies. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Prestige BioPharma a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₩4,608 and ₩5,482; in 9 out of 10, between ₩3,950 and ₩6,395. Estimated annual volatility is 49%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₩329B
- Market cap (USD)
- $248M
- 52-week high
- ₩14,120
- 52-week low
- ₩4,940
- Revenue (12 months)
- ₩26.1B
- Operating margin
- -150.1%
- Net margin
- 0.0%
- Beta
- 0.35
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Prestige BioPharma sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks 950210.KO has traded between ₩4,940 and ₩14,120. Today it is 64.2% below that high and 2% above its low.
Its beta is 0.35: it tends to move less than the market.
About the company
Prestige BioPharma Limited, a biopharmaceutical company, engages in the research and development and marketing of biosimilars, antibody drugs, and vaccines in Singapore.
Want to see everything about Prestige BioPharma?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Prestige BioPharma (950210.KO) fair value?
About ₩6,272 per share according to ATLAS (reasonable range: ₩5,645 to ₩6,899). With the stock at ₩5,050, it is 19% below it.
What is the chance 950210.KO goes up next month?
48%: close to a coin flip. In half of the simulated outcomes, 950210.KO ends the month between ₩4,608 and ₩5,482.
How big is Prestige BioPharma and what is its P/E ratio?
Prestige BioPharma's market capitalization is ₩329B. We do not show a P/E because it has no positive earnings to base one on.
How volatile is 950210.KO?
ATLAS estimates annual volatility at 49%. In a typical month, half of the outcomes end between ₩4,608 and ₩5,482.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer